AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...

Antech, a global veterinary diagnostics, technology and imaging company, today announced the launch of trūRapid™ FOUR, a ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1bn, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, and ...

Contextual AI launches its Grounded Language Model (GLM) that achieves 88% factual accuracy, outperforming major competitors while minimizing hallucinations for enterprise applications.

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

In today's rapidly evolving threat landscape, cybersecurity is more crucial than ever. Advanced persistent threats (APTs) and ...

Group Inc. Director of Corporate Events Angela Spicer says she has a unique technique for tracking customer satisfaction at ...

Additionally, the platform's ability to target distant tumors allows it to act as a viral vector, delivering specific gene therapies ... Calidi’s clinical stage off-the-shelf, universal cell-based ...